Baader Bank Reiterates €22.00 Price Target for MediGene (MDG1)

Share on StockTwits

Baader Bank set a €22.00 ($25.58) price target on MediGene (ETR:MDG1) in a research note issued to investors on Friday. The brokerage currently has a buy rating on the stock.

Separately, Independent Research set a €15.50 ($18.02) target price on MediGene and gave the company a neutral rating in a report on Friday, August 10th.

MediGene stock traded up €0.08 ($0.09) during trading hours on Friday, hitting €10.91 ($12.69). The stock had a trading volume of 66,738 shares, compared to its average volume of 306,207. MediGene has a 1-year low of €8.53 ($9.92) and a 1-year high of €19.27 ($22.41).

About MediGene

Medigene AG, a biotechnology company, develops immunotherapy platforms to treat a range of cancers in various stages. It operates through two segments, Immunotherapies and Other Products. The company develops Dendritic cell vaccines in phase I/II clinical trials; and T-cell receptor-modified T cells and T-cell-specific monoclonal antibodies in preclinical development phase.

Featured Article: Compound Interest

Receive News & Ratings for MediGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediGene and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Jefferies Financial Group Analysts Give TLG Immobilien  a €20.00 Price Target
Jefferies Financial Group Analysts Give TLG Immobilien a €20.00 Price Target
Baader Bank Reiterates €22.00 Price Target for MediGene
Baader Bank Reiterates €22.00 Price Target for MediGene
Coherus Biosciences  Releases Quarterly  Earnings Results, Misses Expectations By $0.08 EPS
Coherus Biosciences Releases Quarterly Earnings Results, Misses Expectations By $0.08 EPS
S&T  Given a €28.50 Price Target at Hauck & Aufhaeuser
S&T Given a €28.50 Price Target at Hauck & Aufhaeuser
Civista Bancshares Inc  Expected to Announce Earnings of $0.42 Per Share
Civista Bancshares Inc Expected to Announce Earnings of $0.42 Per Share
American Express  Receives $112.77 Consensus PT from Analysts
American Express Receives $112.77 Consensus PT from Analysts


Leave a Reply

© 2006-2018 Ticker Report